Papers - HATAKEYAMA SHINGO
-
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
Tomoko Hamaya, Shingo Hatakeyama, Toshikazu Tanaka, Yuka Kubota, Kyo Togashi, Shogo Hosogoe, Naoki Fujita, Ayumu Kusaka, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BJU International 128 ( 4 ) 468 - 476 2021.2
-
Editorial Comment from Dr Hatakeyama and Dr Ohyama to Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma.
Shingo Hatakeyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 2021.2
-
N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
Hirotake Kodama, Tohru Yoneyama, Toshikazu Tanaka, Daisuke Noro, Yuki Tobisawa, Hayato Yamamoto, Shinichiro Suto, Shingo Hatakeyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuko Kakizaki, Shigeyuki Nakaji, Chikara Ohyama
Cancer medicine 10 ( 4 ) 1297 - 1313 2021.2
-
献腎移植を施行したヌーナン症候群の一例
小玉 寛健, 畠山 真吾, 村澤 洋美, 杉山 尚樹, 岡本 亜希子, 山本 勇人, 北原 竜次, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力
日本臨床腎移植学会プログラム・抄録集 54回 132 - 132 2021.2
-
血管内皮細胞を標的としたがん特異的療法の開発
畠山 真吾, 米山 徹, 大山 力
細胞 53 ( 2 ) 99 - 103 2021.2
-
Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.
Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, Fukuda MN, Ohyama C
BMC cancer 21 ( 1 ) 105 2021.1
-
B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.
Tohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Taku Yoshiya, Tsuyoshi Uemura, Takehiro Ishizu, Minoru Suzuki, Shingo Hachinohe, Shintaro Ishiyama, Motohiro Nonaka, Michiko N Fukuda, Chikara Ohyama
BMC cancer 21 ( 1 ) 72 - 72 2021.1
-
Tumor vasculature-targeted <sup>10</sup>B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy.
Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, Fukuda MN, Ohyama C
BMC cancer 21 ( 1 ) 72 2021.1
-
Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis.
Takuma Narita, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Jiro Shimoda, Toshiaki Kawaguchi, Shigeto Ishidoya, Koji Mitsuzuka, Yoichi Arai, Akihiro Ito, Norihiko Tsuchiya, Tomonori Habuchi, Chikara Ohyama
Translational andrology and urology 10 ( 1 ) 417 - 425 2021.1
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).
Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of clinical oncology 26 ( 1 ) 199 - 206 2021.1
-
Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.
Koichi Kido, Shingo Hatakeyama, Kazuyuki Numakura, Toshikazu Tanaka, Masaaki Oikawa, Daisuke Noro, Shogo Hosogoe, Shintaro Narita, Takamitsu Inoue, Takahiro Yoneyama, Hiroyuki Ito, Shoji Nishimura, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama
International journal of clinical oncology 26 ( 1 ) 154 - 162 2021.1
-
Response to Re: Geriatric 8 screening of frailty in patients with prostate cancer.
Shingo Hatakeyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1162 - 1163 2021.1
-
Prognosis of metastatic castration-resistant prostate cancer in the era of the second-generation androgen receptor-targeted agents: A retrospective multicenter study.
Hiromichi Iwamura, Shingo Hatakeyama, Shintaro Narita, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 28 ( 1 ) 125 - 127 2021.1
-
Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 39 ( 3 ) 194.e9 - 194.e16 2021.1
-
Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.
Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Kazutaka Okita, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Lower urinary tract symptoms 13 ( 1 ) 56 - 63 2021.1
-
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.
Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologia internationalis 105 ( 3-4 ) 232 - 239 2021
-
Editorial Comment.
Shingo Hatakeyama, Itsuto Hamano, Chikara Ohyama
The Journal of urology 205 ( 1 ) 107 - 107 2021
-
Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.
Toshikazu Tanaka, Shingo Hatakeyama, Kazuyuki Numakura, Koichi Kido, Daisuke Noro, Masaaki Oikawa, Shogo Hosogoe, Noriko Tokui, Hayato Yamamoto, Shintaro Narita, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1095 - 1100 2021
-
The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).
Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologic oncology 39 ( 3 ) 192.e7 - 192.e14 2021
-
Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy.
Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 39 ( 3 ) 191.e9 - 191.e16 2021